1 June 2023 true No description of principal activity Taxfiler 2024.5 05460424business:CompanyLimitedByGuarantee2023-06-012024-05-31 054604242023-05-31 05460424business:EntityNoLongerTradingButTradedInPast2023-06-012024-05-31 054604242023-06-012024-05-31 05460424business:AuditExempt-NoAccountantsReport2023-06-012024-05-31 05460424business:FilletedAccounts2023-06-012024-05-31 054604242024-05-31 05460424business:Director12023-06-012024-05-31 05460424business:RegisteredOffice2023-06-012024-05-31 054604242023-05-31 05460424core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-05-31 05460424core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-05-31 05460424core:PreviouslyStatedAmount2024-05-31 05460424core:PreviouslyStatedAmount2023-05-31 05460424business:SmallEntities2023-06-012024-05-31 05460424countries:EnglandWales2023-06-012024-05-31 054604242022-06-012023-05-31 iso4217:GBP xbrli:pure
Company Registration No. 05460424 (England and Wales)
SICKLE CELL SUPPORT SCHEME Unaudited accounts for the year ended 31 May 2024
SICKLE CELL SUPPORT SCHEME Unaudited accounts Contents
Page
- 2 -
SICKLE CELL SUPPORT SCHEME Company Information for the year ended 31 May 2024
Director
Olubunmi Otuyemi
Company Number
05460424 (England and Wales)
Registered Office
The Legal Pod 2 West Road Stratford, London E15 3PY
- 3 -
SICKLE CELL SUPPORT SCHEME Statement of financial position as at 31 May 2024
2024 
2023 
Notes
£ 
£ 
Current assets
Cash at bank and in hand
104 
104 
Net current assets
104 
104 
Net assets
104 
104 
Reserves
Profit and loss account
104 
104 
Members' funds
104 
104 
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 9 August 2024 and were signed on its behalf by
Olubunmi Otuyemi Director Company Registration No. 05460424
- 4 -
SICKLE CELL SUPPORT SCHEME Notes to the Accounts for the year ended 31 May 2024
1
Statutory information
SICKLE CELL SUPPORT SCHEME is a private company, limited by guarantee, registered in England and Wales, registration number 05460424. The registered office is The Legal Pod, 2 West Road, Stratford, London, E15 3PY.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Company limited by guarantee
The company is limited by guarantee and has no share capital. Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1.
5
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 5 -